James Hambro & Partners Becton Dickinson & CO Transaction History

James Hambro & Partners

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$232.09 - $256.88 $424,492 - $469,833	-1,829 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$221.92 - $245.94 $33.8 Million - $37.4 Million	-152,271 Reduced 98.81%	1,829 $458,000
Q3 2020 Oct 13, 2020	SELL	$215.77 - $276.76 $577,832 - $741,163	-2,678 Reduced 1.71%	154,100 $35.9 Million
Q2 2020 Jul 13, 2020	BUY	$219.9 - $263.41 $3.61 Million - $4.32 Million	16,403 Added 11.69%	156,778 $37.5 Million
Q1 2020 Apr 16, 2020	BUY	$195.69 - $279.01 $1.18 Million - $1.69 Million	6,046 Added 4.5%	140,375 $32.2 Million
Q4 2019 Feb 04, 2020	BUY	$236.45 - $266.82 $500,564 - $564,857	2,117 Added 1.6%	134,329 $36.5 Million
Q3 2019 Nov 04, 2019	BUY	$230.58 - $256.08 $2.7 Million - $3 Million	11,728 Added 9.73%	132,212 $33.5 Million
Q1 2019 Apr 25, 2019	BUY	$206.05 - $248.17 $1.69 Million - $2.04 Million	8,225 Added 7.33%	120,484 $30.1 Million
Q4 2018 Jan 17, 2019	BUY	$204.73 - $257.93 $8.34 Million - $10.5 Million	40,750 Added 56.99%	112,259 $25.3 Million
Q3 2018 Oct 18, 2018	BUY	$233.07 - $256.0 $9.39 Million - $10.3 Million	40,296 Added 129.1%	71,509 $18.7 Million
Q2 2018 Oct 18, 2018	SELL	$208.1 - $233.85 $3,745 - $4,209	-18 Reduced 0.06%	31,213 $7.48 Million
Q2 2018 Jul 12, 2018	BUY	$208.1 - $233.85 $6.5 Million - $7.3 Million	31,231 New	31,231 $7.49 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

Stay updated on James Hambro & Partners with notifications on news.